Schizophrenia Research Compounds

It has been hypothesized that excess dopamine in mesolimbic neurons may be involved in the positive symptoms of schizophrenia. It has also been hypothesized that serotonergic predominance in the mesocortical system due to an imbalance between the serotonergic system, which suppresses the dopaminergic system, and the dopaminergic system may be involved in the negative symptoms of schizophrenia; many factors, including serotonin and dopamine, have been studied.

FUJIFILM Wako has made a variety of compounds available, including serotonin and dopamine receptor blockers.

Product List

  • Open All
  • Close All

Serotonin/Dopamine Receptor Blockers

Multi-acting Receptor Blocker

Dopamine Receptor Agonist/Antagonist

Dopamine D2 Receptor Blockers

Compounds for Generating Animal Model of Schizophrenia

Cannabinoid Receptor-related Compounds

Serotonin-related Compounds

Noradrenaline-related Compounds

For research use or further manufacturing use only. Not for use in diagnostic procedures.

Product content may differ from the actual image due to minor specification changes etc.

If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.

The prices are list prices in Japan.Please contact your local distributor for your retail price in your region.

Please contact us via the inquiry form.